A large crossover trial evaluating hospital-wide use of lactated Ringer’s solution versus normal saline found no significant difference in patient outcomes.
Aiya Almogaber, PharmD
A May 2025 analysis in JAMA Internal Medicine directly compares apixaban, rivaroxaban, and warfarin across three major U.S. insurance databases and finds that apixaban may provide the most favorable balance of efficacy and safety in routine practice for patients with venous thromboembolism (VTE).
Corey Diamond, PharmD
New research suggests that giving children with gastroenteritis a short supply of ondansetron after an emergency department (ED) visit can reduce the risk of moderate to severe illness in the days that follow.
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in the population of patients with provoked VTE and concomitant enduring risk factors (e.g., autoimmune disorders, chronic lung disease, or obesity) is unclear.
APhA Staff
The efficacy and safety of SGLT-2 inhibitors in patients with advanced CKD, defined as an eGFR <30 mL/min/1.73 m2, has not been adequately studied.